Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Dimetapp Colour Free Elixir

Approved

STANDARD

Dimetapp Colour Free Elixir

Interphil Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 83210dfbd2e3f7d2
Company: Interphil Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: 83210dfbd2e3f7d2
Drug Approval Philippines Name: Dimetapp Colour Free Elixir
Product Name: Dimetapp Colour Free Elixir
Registration Number: DR-XY48500 (FOR EXPORT ONLY)
Brand Name: Dimetapp Colour Free Elixir
Generic Name: Brompheniramine Maleate + Phenylephrine Hydrochloride
Dosage Form: Elixir
Dosage Strength: 2mg/5mg per 5mL
Manufacturer: Interphil Laboratories, Inc.
Issuance Date: 25 November 2022
Expiry Date: 25 November 2027
Classification: Over-the-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

83210dfbd2e3f7d2

Type

Standard

Back to Philippines FDA Approvals

Dimetapp Colour Free Elixir - Philippines FDA Drug Approval Details